Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSGM Biosig Technologies	$5.18 +3.8%	$5.96	$0.23 ▼ $14.11	$162.75M	1.65	875,220 shs	508,600 shs
CLGN CollPlant Biotechnologies	$2.52 +5.0%	$2.01	$1.31 ▼ $5.45	$32.04M	1.47	47,098 shs	44,410 shs
LNSR LENSAR	$12.90 +3.4%	$12.85	$3.80 ▼ $17.31	$153.96M	0.5	56,653 shs	60,540 shs
RCEL Avita Medical	$4.88 +2.7%	$5.36	$3.60 ▼ $14.16	$129.90M	1.63	461,868 shs	226,439 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSGM Biosig Technologies	+3.81%	+4.23%	-6.50%	-1.89%	+1,077.27%
CLGN CollPlant Biotechnologies	+5.00%	-1.18%	+2.86%	+30.57%	-48.15%
LNSR LENSAR	+3.45%	+1.98%	-1.98%	-4.87%	+187.95%
RCEL Avita Medical	+2.74%	-13.32%	-22.04%	-22.29%	-47.13%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSGM Biosig Technologies	1.8644 of 5 stars	3.5	0.0	0.8	1.7	0.6
CLGN CollPlant Biotechnologies	2.6067 of 5 stars	3.5	5.0	1.5	0.0	0.6
LNSR LENSAR	0.9145 of 5 stars	2.0	1.0	2.2	2.5	0.0
RCEL Avita Medical	1.419 of 5 stars	3.2	0.0	1.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSGM Biosig Technologies	3.00	Buy	$10.00	93.05% Upside
CLGN CollPlant Biotechnologies	3.00	Buy	$11.50	356.35% Upside
LNSR LENSAR	2.00	Hold	$15.00	16.28% Upside
RCEL Avita Medical	2.40	Hold	$12.40	154.10% Upside

Current Analyst Ratings Breakdown

Latest CLGN, LNSR, BSGM, and RCEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	CLGN CollPlant Biotechnologies	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$11.00
8/20/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
8/11/2025	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$14.00 ➝ $8.00
8/8/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$19.00 ➝ $18.00
8/8/2025	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$3.00
6/6/2025	BSGM Biosig Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2.50 ➝ $10.00
6/6/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00
5/28/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$14.00 ➝ $12.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSGM Biosig Technologies	$40K	4,068.89	N/A	N/A	($0.11) per share	-47.09
CLGN CollPlant Biotechnologies	$510K	62.85	N/A	N/A	$0.98 per share	2.57
LNSR LENSAR	$53.49M	2.88	N/A	N/A	($1.93) per share	-6.68
RCEL Avita Medical	$64.25M	2.02	N/A	N/A	($0.48) per share	-10.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSGM Biosig Technologies	-$10.33M	N/A	0.00	N/A	N/A	N/A	-10,930.60%	-90.03%	N/A
CLGN CollPlant Biotechnologies	-$16.61M	-$1.13	N/A	N/A	N/A	-541.34%	-94.08%	-68.62%	11/3/2025 (Estimated)
LNSR LENSAR	-$31.40M	-$4.21	N/A	∞	N/A	-84.49%	-737.30%	-72.60%	11/6/2025 (Estimated)
RCEL Avita Medical	-$61.85M	-$1.97	N/A	N/A	N/A	-68.87%	-632.62%	-71.52%	11/6/2025 (Estimated)

Latest CLGN, LNSR, BSGM, and RCEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/20/2025	Q2 2025	CLGN CollPlant Biotechnologies	$0.29	-$0.28	-$0.57	-$0.28	$8.91 million	$0.18 million
8/15/2025	Q2 2025	BSGM Biosig Technologies	-$0.04	-$0.74	-$0.70	-$0.74	N/A	N/A
8/7/2025	Q2 2025	LNSR LENSAR	-$0.0750	-$0.15	-$0.0750	-$0.15	$16.55 million	$11.36 million
8/7/2025	Q2 2025	RCEL Avita Medical	-$0.26	-$0.38	-$0.12	-$0.38	$34.27 million	$18.42 million
6/4/2025	Q1 2025	CLGN CollPlant Biotechnologies	-$0.37	-$0.13	+$0.24	-$0.13	$9.76 million	$2.06 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSGM Biosig Technologies	N/A	N/A	N/A	N/A	N/A
CLGN CollPlant Biotechnologies	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSGM Biosig Technologies	N/A	0.03	2.37
CLGN CollPlant Biotechnologies	N/A	4.60	4.23
LNSR LENSAR	N/A	1.52	0.88
RCEL Avita Medical	9.39	0.58	0.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSGM Biosig Technologies	7.16%
CLGN CollPlant Biotechnologies	21.69%
LNSR LENSAR	40.15%
RCEL Avita Medical	27.66%

Insider Ownership

Company	Insider Ownership
BSGM Biosig Technologies	24.80%
CLGN CollPlant Biotechnologies	9.60%
LNSR LENSAR	38.52%
RCEL Avita Medical	2.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSGM Biosig Technologies	50	31.42 million	23.63 million	No Data
CLGN CollPlant Biotechnologies	70	12.72 million	11.50 million	Optionable
LNSR LENSAR	110	11.94 million	7.34 million	Optionable
RCEL Avita Medical	130	26.62 million	25.87 million	Optionable

CLGN, LNSR, BSGM, and RCEL Headlines

Recent News About These Companies

Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors

August 22 at 5:52 PM | globenewswire.com

INVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLC

August 22 at 12:04 PM | globenewswire.com

AVITA Medical, Inc. (RCEL) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 21 at 10:51 PM | tmcnet.com

AVITA Medical Announces September Investor Conference Participation

August 21 at 4:05 PM | globenewswire.com

Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

August 21 at 3:00 PM | businesswire.com

AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 21 at 12:35 PM | businesswire.com

Robert Mcnamara Acquires 10,000 Shares of Avita Medical (NASDAQ:RCEL) Stock

August 21 at 8:54 AM | insidertrades.com

Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 20 at 9:38 PM | tmcnet.com

Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 20 at 5:39 PM | businesswire.com

Avita Medical Announces $15M Equity Placement Agreement

August 19, 2025 | msn.com

Cantor Fitzgerald Expects Reduced Earnings for Avita Medical

August 17, 2025 | marketbeat.com

Cantor Fitzgerald Forecasts Lower Earnings for Avita Medical

August 17, 2025 | americanbankingnews.com

Lake Street Capital Lowers Avita Medical (NASDAQ:RCEL) Price Target to $8.00

August 14, 2025 | americanbankingnews.com

Avita Medical Raises $15M in Private Placement

August 13, 2025 | msn.com

Analysts Are More Bearish On AVITA Medical, Inc. (NASDAQ:RCEL) Than They Used To Be

August 13, 2025 | finance.yahoo.com

Avita Medical completes Australian equity raise

August 13, 2025 | msn.com

AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2025 Earnings Call Transcript

August 13, 2025 | msn.com

Avita Medical’s Earnings Call: Growth Amid Challenges

August 13, 2025 | msn.com

Lake Street Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price

August 12, 2025 | marketbeat.com

AVITA Medical Successfully Completes Australian Equity Raise

August 12, 2025 | globenewswire.com

AVITA Medical to Host Investor Webinar Briefing

August 10, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLGN, LNSR, BSGM, and RCEL Company Descriptions

Biosig Technologies NASDAQ:BSGM

$5.18 +0.19 (+3.81%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.20 +0.02 (+0.29%)

As of 08/22/2025 07:57 PM Eastern

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

CollPlant Biotechnologies NASDAQ:CLGN

$2.52 +0.12 (+5.00%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$2.52 0.00 (-0.20%)

As of 08/22/2025 07:31 PM Eastern

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.

LENSAR NASDAQ:LNSR

$12.90 +0.43 (+3.45%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$12.90 0.00 (0.00%)

As of 08/22/2025 04:10 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Avita Medical NASDAQ:RCEL

$4.88 +0.13 (+2.74%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$4.88 0.00 (0.00%)

As of 08/22/2025 07:29 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time